Form 4: ICAD Director Rakesh Patel Reports Full Disposition of Shares and Options Following RadNet Merger

ICAD Director Rakesh Patel reported the complete disposition of his common stock and stock options in ICAD, Inc. due to the company's merger with RadNet, Inc. on July 17, 2025.

Summary

• Rakesh Patel, a Director of ICAD, Inc., reported the disposition of all his beneficial ownership in ICAD common stock and derivative securities.
• This disposition occurred on July 17, 2025, which was the effective time of the merger between ICAD, Inc. and Trio Merger Sub, Inc., a wholly-owned subsidiary of RadNet, Inc.
• Under the merger agreement, each outstanding share of ICAD common stock was automatically canceled and converted into the right to receive 0.0677 shares of RadNet common stock, plus cash in lieu of fractional shares.
• Mr. Patel disposed of 62,217 shares of ICAD common stock, resulting in 0 shares beneficially owned following the transaction.
• ICAD stock options with an exercise price less than $7.20 were assumed by RadNet and converted into options to purchase RadNet stock, adjusted by the 0.0677 exchange ratio.
• ICAD stock options with an exercise price of $7.20 or greater terminated without any consideration payable.
• Mr. Patel disposed of various stock options with exercise prices ranging from $1.49 to $18.00, totaling 270,050 options, resulting in 0 derivative securities beneficially owned following the transaction.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive from a corporate action perspective, as the merger successfully closed, providing an exit for shareholders. However, the termination of certain options without consideration introduces a negative aspect for specific option holders.

Positives

• The merger provides a clear exit strategy for ICAD shareholders, converting their shares into RadNet stock.
• Eligible stock options were assumed and converted into RadNet options, preserving some value for option holders.

Negatives

• ICAD stock options with an exercise price of $7.20 or greater terminated without any consideration, resulting in a loss of value for those specific options.
• ICAD, Inc. ceased to exist as an independent publicly traded entity following the merger.

Risks

• The risk of options with an exercise price of $7.20 or greater terminating without consideration has materialized for holders of such options.

Future Outlook

The document details the completion of a merger, indicating a change in the corporate structure of ICAD, Inc. and its integration into RadNet, Inc. There are no forward-looking statements regarding future performance or guidance for the combined entity.

Industry Context

This Form 4 filing reflects the finalization of a significant corporate consolidation within the healthcare technology and medical imaging sector. ICAD, Inc., a company focused on AI-powered cancer detection, has been acquired by RadNet, Inc., a leading provider of outpatient diagnostic imaging services. Such mergers are common in industries seeking to achieve scale, integrate complementary technologies, or expand market reach.

Stakeholder Impact

• Shareholders of ICAD, Inc.: Their shares were converted into RadNet stock at a fixed exchange ratio, providing liquidity and a stake in the acquiring company.
• Option Holders of ICAD, Inc.: Those with eligible options saw their options converted to RadNet options, while those with out-of-the-money or high-strike options (exercise price equal to or greater than $7.20) had their options terminated without consideration.
• Employees of ICAD, Inc.: The merger likely impacts their employment status and compensation structure, particularly regarding equity incentives, as the company is now part of RadNet.

Next Steps

• Integration of ICAD's operations and technology into RadNet, Inc.
• Shareholders of ICAD, Inc. receiving RadNet stock based on the exchange ratio.

Key Dates

Keywords

SEC Form 4, Merger, Acquisition, ICAD Inc., RadNet Inc., Stock Disposition, Option Conversion, Corporate Action, Director Holdings, Insider Transaction